Department of Otorhinolaryngology, Clinical Medical College of Yangzhou University, Yangzhou, China.
Department of Radiology, Clinical Medical College of Yangzhou University, Yangzhou, China.
J Int Adv Otol. 2023 Mar;19(2):149-154. doi: 10.5152/iao.2023.22850.
Adenoid cystic carcinoma of the external auditory canal is a rare primary malignancy, and surgery is the primary management strategy. This study aims to optimize management strategies and improve prognosis of adenoid cystic carcinoma of the external auditory canal.
Seventeen patients with adenoid cystic carcinoma of external auditory canal who had been admitted to a single institution from January 2008 to March 2019 were recruited and retrospectively reviewed. Among patients with T1 tumors, 2 underwent local external auditory canal resection, 1 received lateral temporal bone resection+superficial parotidectomy. Among patients with T2 tumors, all 5 patients underwent lateral temporal bone resection+superficial parotidectomy. Among patients with T3 tumors, 3 underwent subtotal temporal bone resection+superficial parotidectomy, 2 underwent subtotal temporal bone resection+superficial parotidectomy+radiotherapy, and 1 underwent extended temporal bone resection+superficial parotidectomy+radiotherapy. Among patients with T4 tumors, 2 underwent subtotal temporal bone resection+superficial parotidectomy and 1 underwent extended temporal bone resection+total parotidectomy+radiotherapy.
The common manifestations included otalgia (82.4%), hearing loss (23.5%), external auditory canal mass (23.5%), otorrhea (17.6%), and aural fullness (5.9%). In the study, 5/17 (29.4%) patients had been misdiagnosed preoperatively, 5/17 (29.4%) patients revealed local recurrence, and 3/17 patients (17.6%) were identified with distant metastasis postoperatively. The 3- and 5-year overall survival rates were 88.2% and 82.3%, respectively. There was no significant difference in overall survival (P=.746) and disease-free survival (P=.933) between patients receiving different surgical approaches. Three out of 17 patients (17.6%) died of T2, T3, and T4 diseases, respectively.
Otalgia is the most common manifestation of adenoid cystic carcinoma of the external auditory canal, and misdiagnosis is frequently encountered. Surgery is the preferred therapy, and local resection is associated with relapse, lateral temporal bone resection is strongly recommended in patients with early-stage tumor. Regular follow-up should be routinely conducted postoperatively to early identify local recurrence.
外耳道腺样囊性癌是一种罕见的原发性恶性肿瘤,手术是主要的治疗策略。本研究旨在优化外耳道腺样囊性癌的治疗策略,改善其预后。
回顾性分析 2008 年 1 月至 2019 年 3 月期间在一家医疗机构接受治疗的 17 例外耳道腺样囊性癌患者。T1 肿瘤患者中,2 例行局部外耳道切除术,1 例行颞骨外侧切除术+腮腺浅叶切除术。T2 肿瘤患者中,5 例均行颞骨外侧切除术+腮腺浅叶切除术。T3 肿瘤患者中,3 例行颞骨次全切除术+腮腺浅叶切除术,2 例行颞骨次全切除术+腮腺浅叶切除术+放疗,1 例行扩大颞骨切除术+腮腺浅叶切除术+放疗。T4 肿瘤患者中,2 例行颞骨次全切除术+腮腺浅叶切除术,1 例行扩大颞骨切除术+腮腺全切除术+放疗。
常见表现包括耳痛(82.4%)、听力损失(23.5%)、外耳道肿块(23.5%)、耳漏(17.6%)和耳部饱满感(5.9%)。本研究中,术前误诊率为 29.4%(5/17),局部复发率为 29.4%(5/17),术后远处转移率为 17.6%(3/17)。3 年和 5 年总生存率分别为 88.2%和 82.3%。不同手术方式的患者总生存率(P=.746)和无病生存率(P=.933)差异无统计学意义。17 例患者中有 3 例(17.6%)分别死于 T2、T3 和 T4 期疾病。
耳痛是外耳道腺样囊性癌最常见的表现,误诊率较高。手术是首选治疗方法,局部切除与复发相关,建议早期肿瘤患者行颞骨外侧切除术。术后应定期进行常规随访,以便早期发现局部复发。